Registration of Nutraceuticals and Reporting Adverse Events of Dietary Supplements in USA

  • NAVYA BR Department of Pharmaceutical Regulatory Affairs, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Acharya Post, Hesaraghatta Main Road, Bengaluru-560107.
  • Shanthakumar GS Department of Pharmaceutical Regulatory Affairs, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Acharya Post, Hesaraghatta Main Road, Bengaluru-560107.
  • Shrikanth P Department of Pharmaceutical Regulatory Affairs, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Acharya Post, Hesaraghatta Main Road, Bengaluru-560107.
  • Ayushi Agrawal Department of Pharmaceutical Regulatory Affairs, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Acharya Post, Hesaraghatta Main Road, Bengaluru-560107.
  • Shoukat Ali Department of Pharmaceutical Regulatory Affairs, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Acharya Post, Hesaraghatta Main Road, Bengaluru-560107.
DOI: https://doi.org/10.32553/jbpr.v9i4.794

Abstract

 The US FDA characterizes Nutraceuticals as "Dietary Supplements" Under DSHEA (Dietary Supplement Health Education Act-1994). In USA Food and Drug Administration (FDA) controls nutraceutical under different guidelines. According to DSHEA producer should make sure that nutraceutical is safe before it is promoted. The FDA concentrating on quality and safety of the product as these are used by humans. As food items are coming to starting with one nation then onto the next, keeping up safety and quality principles according to different regulatory frameworks set by the individual governments gets significant.

Published
2020-09-03
How to Cite
BR, N., GS, S., P, S., Agrawal, A., & Ali, S. (2020). Registration of Nutraceuticals and Reporting Adverse Events of Dietary Supplements in USA. Journal of Biomedical and Pharmaceutical Research, 9(4). https://doi.org/10.32553/jbpr.v9i4.794
Issue
Vol. 9 No. 4 (2020)
Section
Review Articles

Creative Commons LicenseJournal of Biomedical and Pharmaceutical Research by Articles is licensed under a Creative Commons Attribution 4.0 International License.